Literature DB >> 18615471

Inverted human umbilical arteries with tunable wall thicknesses for nerve regeneration.

Thomas Crouzier1, Trosper McClendon, Zehra Tosun, Peter S McFetridge.   

Abstract

Tubular nerve guides have shown a potential to bridge nerve defects, by directing neuronal elongation, localizing growth factors, and inhibiting fibrotic cellular ingrowth. These investigations describe a novel acellular scaffold derived from the human umbilical cord artery that aims to enhance nerve regeneration by presenting a unique mechanical and chemical environment to the damaged nerve ends. A rapid, semiautomated dissection technique is described that isolates the human umbilical artery (HUA) from the umbilical cord, after which the vessel is decellularized using sodium dodecyl sulfate (SDS). The artery is turned inside out to produce a 3D scaffold, that unlike previous vessels for nerve repair, is more resistant to collapse. The scaffold has the potential as either an acellular bridge-implant, or for in vitro nerve regeneration. Stress-strain relationships and suture retention were assessed to determine whether the material had similar mechanical properties to native nerves. A dual process-flow perfusion bioreactor was developed to assess glucose mass transfer, and to investigate the culture of neuronal-like PC12 cells within the scaffold. These investigations have shown the automated dissecting method yields a smooth tubular scaffold, where wall thickness can be tuned to alter the mechanical behavior of the scaffold. Inverting the scaffold prevents collapse, with the decellularized iHUA having comparable mechanical properties to native nerves. Bioreactor cultures with PC12 cells seeded within iHUA lumenal void were shown to adhere and migrate into the preexisting ECM after 11 days of culture. These investigations show the potential of the iHUA as a unique 3D scaffold that may enhance nerve regeneration. 2008 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18615471     DOI: 10.1002/jbm.a.32103

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  7 in total

1.  Precision microchannel scaffolds for central and peripheral nervous system repair.

Authors:  Daniel Lynam; Bridget Bednark; Chelsea Peterson; David Welker; Mingyong Gao; Jeffrey S Sakamoto
Journal:  J Mater Sci Mater Med       Date:  2011-07-16       Impact factor: 3.896

2.  Development of a mechanically tuneable 3D scaffold for vascular reconstruction.

Authors:  Maritza Rodriguez; Cassandra Juran; Mark McClendon; Cyril Eyadiel; Peter S McFetridge
Journal:  J Biomed Mater Res A       Date:  2012-07-24       Impact factor: 4.396

3.  Preimplantation processing of ex vivo-derived vascular biomaterials: effects on peripheral cell adhesion.

Authors:  Joseph S Uzarski; Aurore B Van De Walle; Peter S McFetridge
Journal:  J Biomed Mater Res A       Date:  2012-07-24       Impact factor: 4.396

Review 4.  Human Perinatal-Derived Biomaterials.

Authors:  Marc C Moore; Aurore Van De Walle; Jerry Chang; Cassandra Juran; Peter S McFetridge
Journal:  Adv Healthc Mater       Date:  2017-08-07       Impact factor: 9.933

Review 5.  Umbilical cord tissue cryopreservation: a short review.

Authors:  Irina Arutyunyan; Timur Fatkhudinov; Gennady Sukhikh
Journal:  Stem Cell Res Ther       Date:  2018-09-15       Impact factor: 6.832

Review 6.  ECM-based materials in cardiovascular applications: Inherent healing potential and augmentation of native regenerative processes.

Authors:  Anna V Piterina; Aidan J Cloonan; Claire L Meaney; Laura M Davis; Anthony Callanan; Michael T Walsh; Tim M McGloughlin
Journal:  Int J Mol Sci       Date:  2009-11-20       Impact factor: 6.208

7.  Effects of nerve growth factor and basic fibroblast growth factor dual gene modification on rat bone marrow mesenchymal stem cell differentiation into neuron-like cells in vitro.

Authors:  Yang Hu; Yan Zhang; Kang Tian; Chong Xun; Shouyu Wang; Decheng Lv
Journal:  Mol Med Rep       Date:  2015-11-11       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.